In addition, Pang et al. have suggested that the genetic polymorphism of HSPB1 rs2868371 was connected with severe RP after chemoradiotherapy for NSCLC patients, especially in the patients with grade ≥3 RP [44]. This evidence concerns the gene HSPB1 and non-small cell lung carcinoma.